Cargando…

First person – Geon Seong Lee

First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Geon Seong Lee is first author on ‘ Morc2a p.S87L mutant mice develop peripheral and centra...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Company of Biologists Ltd 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560495/
http://dx.doi.org/10.1242/dmm.049312
_version_ 1784592939632033792
collection PubMed
description First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Geon Seong Lee is first author on ‘ Morc2a p.S87L mutant mice develop peripheral and central neuropathies associated with neuronal DNA damage and apoptosis’, published in DMM. Geon Seong is a PhD student in the lab of Su Cheong Yeom at Seoul National University, Pyeongchang, South Korea, investigating gene-editing therapy for single-nucleotide polymorphism-mediated genetic disorder.
format Online
Article
Text
id pubmed-8560495
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Company of Biologists Ltd
record_format MEDLINE/PubMed
spelling pubmed-85604952021-11-02 First person – Geon Seong Lee Dis Model Mech First Person First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Geon Seong Lee is first author on ‘ Morc2a p.S87L mutant mice develop peripheral and central neuropathies associated with neuronal DNA damage and apoptosis’, published in DMM. Geon Seong is a PhD student in the lab of Su Cheong Yeom at Seoul National University, Pyeongchang, South Korea, investigating gene-editing therapy for single-nucleotide polymorphism-mediated genetic disorder. The Company of Biologists Ltd 2021-10-25 /pmc/articles/PMC8560495/ http://dx.doi.org/10.1242/dmm.049312 Text en © 2021. Published by The Company of Biologists Ltd https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
spellingShingle First Person
First person – Geon Seong Lee
title First person – Geon Seong Lee
title_full First person – Geon Seong Lee
title_fullStr First person – Geon Seong Lee
title_full_unstemmed First person – Geon Seong Lee
title_short First person – Geon Seong Lee
title_sort first person – geon seong lee
topic First Person
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560495/
http://dx.doi.org/10.1242/dmm.049312